
| Full details for "Pro-collagen 3 amino-terminal peptide". | |
|---|---|
Name |
Pro-collagen 3 amino-terminal peptide |
Alternative name/Profile |
PIIINP |
Department |
Biochemistry |
Investigation |
PIIINP may be increased in patients with liver fibrosis and cirrhosis. It is used in St James's Hospital to assess hepatic fibrosis in patients on long-term Methotrexate treatment. |
Specimen type |
Serum |
Sample type |
Sample should be separated within one hour and serum frozen. Lithium Heparin plasma is not a suitable sample type for this assay. Highly lipemic and haemolysed samples will not be processed |
Sample container & volume |
1 X 5 mL Red tube |
Frequency of analysis |
|
Turnaround time |
28 days |
Availability |
|
Notes |
Serum Pro-collagen 3 N-Terminal Peptide P3NP is the amino terminal peptide of type 3 procollagen, released from the precursor peptide during the synthesis and deposition of type 3 collagen. P3NP in the serum can be derived from the synthesis of new type 3 collagen or from the degradation of existing type III collagen fibrils. Clinical utility of serum P3NP analysis
Helpful links https://www.southtees.nhs.uk/services/pathology/tests/type-iii-procollagen-peptide-piiinp/ |
Related links |
|
Reference range |
Reference Range = 1.7 - 4.2 µg/L Consider liver biopsy in adult patients treated with Methotrexate for psoriasis if: Consider withdrawal of Methotrexate if: |
Last updated |
Fri, 14 Nov 2025 15:17:04 GMT |